166 related articles for article (PubMed ID: 10789489)
1. Cancer chemoprevention.
Brenner DE
Crit Rev Oncol Hematol; 2000 Mar; 33(3):155-6. PubMed ID: 10789489
[No Abstract] [Full Text] [Related]
2. Chemoprevention of cancer--focusing on clinical trials.
Kakizoe T
Jpn J Clin Oncol; 2003 Sep; 33(9):421-42. PubMed ID: 14594936
[TBL] [Abstract][Full Text] [Related]
3. Chemoprevention of cancer.
Tsao AS; Kim ES; Hong WK
CA Cancer J Clin; 2004; 54(3):150-80. PubMed ID: 15195789
[TBL] [Abstract][Full Text] [Related]
4. Chemoprevention of lung cancers: lessons from CARET, the beta-carotene and retinol efficacy trial, and prospects for the future.
Omenn GS
Eur J Cancer Prev; 2007 Jun; 16(3):184-91. PubMed ID: 17415088
[TBL] [Abstract][Full Text] [Related]
5. Chemoprevention of breast cancer with tamoxifen.
Cuzick J
IARC Sci Publ; 1996; (136):95-109. PubMed ID: 8791120
[No Abstract] [Full Text] [Related]
6. The role of chemoprevention in cancer control.
Buiatti E
Salud Publica Mex; 1997; 39(4):310-7. PubMed ID: 9337563
[TBL] [Abstract][Full Text] [Related]
7. Chemoprevention of lung cancer: the rise and demise of beta-carotene.
Omenn GS
Annu Rev Public Health; 1998; 19():73-99. PubMed ID: 9611613
[TBL] [Abstract][Full Text] [Related]
8. Re: Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy trial.
Challem JJ
J Natl Cancer Inst; 1997 Feb; 89(4):325-6. PubMed ID: 9048840
[No Abstract] [Full Text] [Related]
9. Tamoxifen chemoprevention--are we throwing out the baby with the bathwater?
Greenspan EM
Cancer Invest; 1994; 12(6):671-5. PubMed ID: 7994603
[No Abstract] [Full Text] [Related]
10. Interpretations of the Linxian vitamin supplement chemoprevention trials.
Omenn GS
Epidemiology; 1998 Jan; 9(1):1-4. PubMed ID: 9430258
[No Abstract] [Full Text] [Related]
11. Chemoprevention of lung cancer: the beta-Carotene and Retinol Efficacy Trial (CARET) in high-risk smokers and asbestos-exposed workers.
Omenn GS; Goodman G; Thornquist M; Barnhart S; Balmes J; Cherniack M; Cullen M; Glass A; Keogh J; Liu D; Meyskens F; Perloff M; Valanis B; Williams J
IARC Sci Publ; 1996; (136):67-85. PubMed ID: 8791118
[No Abstract] [Full Text] [Related]
12. Tamoxifen and raloxifene may benefit women at high risk for breast cancer.
Rollins G
Rep Med Guidel Outcomes Res; 2002 Jul; 13(14):1-2, 5. PubMed ID: 12518771
[No Abstract] [Full Text] [Related]
13. Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials.
Kelloff GJ; Boone CW; Steele VE; Crowell JA; Lubet R; Sigman CC
Cancer Res; 1994 Apr; 54(7 Suppl):2015s-2024s. PubMed ID: 8137331
[TBL] [Abstract][Full Text] [Related]
14. Chemoprevention of cancer.
Szarka CE; Grana G; Engstrom PF
Curr Probl Cancer; 1994; 18(1):6-79. PubMed ID: 8005001
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen or raloxifene for breast cancer chemoprevention: a tale of two choices--point.
Jordan VC
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2207-9. PubMed ID: 18006908
[No Abstract] [Full Text] [Related]
16. [Chemoprevention of breast cancer. Impact of a new therapeutic strategy].
Kattan J; Ghosn M
J Med Liban; 1999; 47(5):284-5. PubMed ID: 10887527
[No Abstract] [Full Text] [Related]
17. [Chemoprevention of breast cancer. Clinical trials in pharmacological prevention].
Ricart JJ
Medicina (B Aires); 2004; 64(1):66-72. PubMed ID: 15034961
[TBL] [Abstract][Full Text] [Related]
18. [Chemoprevention of breast cancer by tamoxifen: should we still ask this question?].
Sasco AJ
Rev Epidemiol Sante Publique; 1999 Jun; 47(3):279-85. PubMed ID: 10422121
[TBL] [Abstract][Full Text] [Related]
19. Chemoprevention research in Europe.
Hakama M
Int J Cancer; 1997; Suppl 10():30-3. PubMed ID: 9209017
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen Chemoprevention--End of the Road?
Narod SA
JAMA Oncol; 2015 Nov; 1(8):1033-4. PubMed ID: 26247918
[No Abstract] [Full Text] [Related]
[Next] [New Search]
